Position in SANA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,062,103
+$11,575,145 QoQ
Shares Held
5,748,454
+95.1% QoQ
Ownership
1.92%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Derivatives in SANA
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$401,150
PutShares
113,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. SANA ranks #84 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in SANA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,062,103 | 5,748,454 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,486,958 | 2,946,861 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,828,040 | 1,186,251 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $401,150 | 113,000 | Put | Defined | 2026-02-03 | |
| 2025-09-30 | $3,257,627 | 917,642 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,415,580 | 884,828 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $308,490 | 113,000 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $189,840 | 113,000 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $888,470 | 528,852 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,844,854 | 1,131,813 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,228,497 | 1,016,466 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,969,510 | 910,167 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,480,270 | 548,027 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,965,701 | 481,790 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,557,262 | 402,394 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,260,273 | 379,241 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,231,547 | 682,431 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,636,947 | 667,582 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,751,684 | 458,614 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,345,014 | 364,699 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,135,387 | 379,587 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $847,080 | 54,721 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $253,574 | 11,260 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $241,187 | 12,268 | Shares | Defined | 2021-09-13 | |
| 2021-06-30 | $983,000 | 50,000 | Call | Defined | 2021-09-13 | |
| 2021-03-31 | $289,146 | 8,639 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||